Dr. Michael Timothy Tees, MD, MPH

Dr. Tees practices at HealthONE Clinic Services - Oncology Hematology in Denver, Colorado.

Dr. Tees' NPI, 1407023385, was assigned on May 10, 2008. Dr. Tees graduated from Tulane School of Medicine in 2008. Dr. Tees holds Colorado license 55473.

Dr. Tees' primary practice is HealthONE Clinic Services - Oncology Hematology, at 1721 E 19th Ave, Denver, CO 80218 in Denver County. The practice phone is (720) 754-4800.

Dr. Tees' primary practice is HealthONE Clinic Services - Oncology Hematology in Denver, Colorado. Dr. Tees is also affiliated with HCA HealthONE Presbyterian St. Luke's. The medical group on file is HCA HealthONE Physicians. Dmand AI also links Dr. Tees to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tees practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Tees' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Tees is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Tees' licenses on file in 5 states: Colorado, New Mexico, Nevada, Florida and New York.

Dmand AI lists chronic leukemia, lymphoma and multiple myeloma among the conditions Dr. Tees treats.

CMS data shows 8,931 Medicare services from Dr. Tees across 14 procedure codes in 2024, for 265 Medicare patients. Medicare paid $336,335 for them. Every service was in an office.

CMS counts 265 Medicare patients who saw Dr. Tees in 2024. The largest group is 65 to 74, with 151 patients. 67% of them have high cholesterol, and 65% have high blood pressure. 6% are also on Medicaid. Their average risk score is 2.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tees' median patient age at 67, with 41% women.

In 2024, Dr. Tees wrote 1,357 Medicare Part D claims for 107 patients. 76% of them were for generic drugs. CMS names the drug for 1,069 of them, across 35 drugs with 11 or more claims each, at $2,390,990 in total drug cost. In 2023, CMS named 849 claims across 34 drugs.

Dr. Tees accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tees as offering telehealth.

Dmand AI links 15 papers to Dr. Tees, published from 2012 to 2025. 2025 was the busiest year, with 3. The most frequent topics are Antigens, CD19, Antineoplastic Combined Chemotherapy Protocols and Immunotherapy, Adoptive. Dr. Tees has published most often in Am J Ther. Dr. Tees' most frequent co-authors are Ian Winchester Flinn, MD, Navneet Singh Majhail, MD and Shahbaz Ali Malik, MD.

Dmand AI links Dr. Tees to 4 clinical trials, 2 of them phase 1/2 studies. 2 are still active or recruiting. Conditions studied include Lymphoma, B-Cell, Marginal Zone, Lymphoma, T-Cell, Peripheral and Multiple Myeloma. Washington University School of Medicine sponsors the most, 2.

CMS Open Payments shows 271 general payments to Dr. Tees from 30 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Pharmacyclics LLC, An AbbVie Company paid the most, $42,790. It also lists 1 research payment totaling $1,018 in 2024.

Dr. Tees graduated from Tulane School of Medicine in 2008. Dr. Tees is a member of ACP, American Society for Transplantation and Cellular Therapy, ASCO and ASH.

Dr. Tees is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.